Covalon Technologies Ltd. (COV:TSXV) closed at $4.21 on November 13, 2026, up 0.96% on the day. The stock trades 8.3% below its 52-week high of $4.59 and 171.6% above its 52-week low of $1.55. Over the past year, it gained 111.6%. Covalon Technologies Ltd. is part of the Life Sciences sector (Biotechnology).
In 252 trading sessions since November 13, 2025, COV closed higher on 109 days (43%). Its best day was August 27, 2026 (+27.95%) and its worst was September 30, 2026 (-15.40%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 3 times.
Covalon Technologies Ltd is engaged in the business of developing, licensing, and selling medical technologies. The Company generates its revenues through development contracts, licensing agreements, distribution contracts and sales.
Find more stocks like COV with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.